Capital Change Notice
21 June 2021
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.
Section 1: Issuer information
Name of issuer | AFT Pharmaceuticals Limited |
NZX ticker code | AFT |
Class of financial product | Ordinary shares |
ISIN (If unknown, check on NZX website) | NZAFTE0001S4 |
Currency | NZD |
Section 2: Capital change details | |
Number issued | 10,000 |
Nominal value (if any) | Not applicable |
Issue price per security | $2.80 |
Nature of the payment | Not applicable |
Amount paid up (if not in full) | In full |
Percentage of total class of Financial Products issued | 0.01% |
(calculated on the number of Financial Products of the | |
Class, excluding any Treasury Stock, in existence) | |
For an issue of Convertible Financial Products or | Not applicable |
Options, the principal terms of Conversion | |
Reason for issue and specific authority for issue | 10,000 shares were issued to an |
employee exercising options under the | |
AFT Pharmaceuticals Limited Long | |
Term Incentive Plan | |
Total number of Financial Products of the Class after | 104,663,875 |
the issue (excluding Treasury Stock) and the total | |
number of Financial Products of the Class held as | |
Treasury Stock after the issue. | |
Specific authority for the issue, including a reference | Directors' resolution, Listing Rule 4.6 |
to the rule pursuant to which the issue is made | |
Terms or details of the issue (for example: restrictions, | The ordinary shares issued rank pari |
escrow arrangements) | passu with the existing ordinary shares |
Date of issue | 18 June 2021 |
AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com
Section 3: Authority for this announcement and contact person
Name of person authorised to make this | Malcolm Tubby |
announcement | |
Contact person for this announcement | Malcolm Tubby |
Contact phone number | +64 9 488 0232 |
Contact email address | malcolm@aftpharm.com |
Date of release through MAP | 21 June 2021 |
AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com
Attachments
- Original document
- Permalink
Disclaimer
AFT Pharmaceuticals Limited published this content on 21 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 June 2021 23:12:03 UTC.